TABLE 1.
Primary HLH | Gene | Protein | Pathophysiology | Functional testing |
Familial HLH (FHL) | ||||
FHL-1 | Unknown | Unknown | ||
FHL-2 | PFR1 | Perforin | Lack of perforin expression in lytic granules | Perforin expression |
FHL-3 | UNC13D | Munc13-4 | Deficiency in fusion of lytic granule with plasma membrane | Degranulation |
FHL-4 | STX11 | Syntaxin11 | Deficiency in fusion of lytic granule with plasma membrane | Degranulation |
FHL-5 | STXBP2 | Munc18-2 | Deficiency in fusion of lytic granule with plasma membrane | Degranulation |
Other immunodeficiency syndromes with defect in degranulation | ||||
GS-II | RAB27A | Rab27a | Deficiency in docking of lytic granule to the plasma membrane | Degranulation hair microscopy |
CHS | LYST | Lyst | Defect in maturation of vesicles into secretory cytotoxic granules | Degranulation hair microscopy |
— | ||||
Other inborn errors of immunity | Gene | Protein | Pathophysiology | Functional testing |
Immunodeficiency syndromes with HLH as a frequent manifestation | ||||
XLP-1 | SH2D1A | SAP | Defective killing of EBV infected B-cells by CD8 and NK cells | SAP expression |
XLP-2 | BIRC4 | XIAP | Impaired inhibition of inflammasome activity | XIAP expression L18MDP assay |
TIM3 deficiency | HAVCR2 | TIM3 | Persistent T cell activation and increased production of inflammatory cytokines | TIM3 expression |
Immunodeficiency syndromes with HLH as an occasional manifestation | ||||
Chronic granulomatous disease (CGD) | CYBB, CYBA, NCF1, NCF2, NCF4 | Components of NADPH oxidase | Excessive inflammatory responses due to altered inflammasome regulation by NADPH oxidase? | Oxidative Burst |
(S)CID | >50 genes | various | Lack of pathogen control | Lymphocyte phenotyping |
Wiskott-Aldrich syndrome | WAS | WASP | Lack of pathogen control Impaired cytoskeleton-inflammasome interaction? |
WASP expression (FACS) |
CD27 deficiency | CD27 | CD27 | Impaired co-stimulation of T cells Lack of EBV control |
CD27 expression |
ITK deficiency | ITK | ITK | Impaired TCR mediated signaling Lack of EBV control |
ITK expression |
IFNγ receptor deficiency | IFNGR1 IFNGR2 | IFN-gamma receptor | Lack of pathogen control (mycobacteria, salmonella) | STAT1 phosphorylation |
ALPS | FAS (het) FASLG |
FAS FASLG |
Defects in Fas ligand-mediated elimination of activated lymphocytes | TCR DNT Vitamin B12, soluble FasL |
Autoinflammatory diseases with HLH as a frequent manifestation | ||||
NLRC4 gain of function | NLRC4 (het) | NLRC4 | Constitutive inflammasome activation IL-1β/IL-18 production | Genetic testing |
CDC42 mutations | CDC42 (het) | CDC42 | Impaired cytoskeleton-inflammasome interaction? | Genetic testing |